Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Landray

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Trials|October 30, 2024
Retraction Note: Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatmentsCaroline Cake, Emma Ogburn, Heather Pinches, et al.
Mayo Clinic Proceedings|November 6, 2017
The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysisSimon D S Fraser, Anthony Fenton, Scott Harris, et al.
The Lancet. Diabetes & Endocrinology|August 2, 2016
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials, William Herrington, Jonathan Emberson, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|May 9, 2013
[ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study]Jia-min Liu, Lei Ge, Jing Li, et al.
Plos Medicine|April 1, 2015
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old ageCathie Sudlow, John Gallacher, Naomi Allen, et al.
Chinese Medical Journal|July 18, 2012
Underuse of statins in patients with atherosclerotic ischemic stroke in ChinaXi Li, Yan Gao, Jing Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney diseaseColin Baigent, Martin Landray, Craig Leaper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.
Chinese Medical Journal|December 21, 2012
Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patientsJing Li, Yi-ping Chen, Xi Li, et al.
JAMA Cardiology|December 16, 2016
Feasibility of Obtaining Measures of Lifestyle From a Smartphone App: The MyHeart Counts Cardiovascular Health StudyMichael V McConnell, Anna Shcherbina, Aleksandra Pavlovic, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Trials|October 30, 2024
Retraction Note: Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatmentsCaroline Cake, Emma Ogburn, Heather Pinches, et al.
Mayo Clinic Proceedings|November 6, 2017
The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysisSimon D S Fraser, Anthony Fenton, Scott Harris, et al.
The Lancet. Diabetes & Endocrinology|August 2, 2016
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials, William Herrington, Jonathan Emberson, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|May 9, 2013
[ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study]Jia-min Liu, Lei Ge, Jing Li, et al.
Plos Medicine|April 1, 2015
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old ageCathie Sudlow, John Gallacher, Naomi Allen, et al.
Chinese Medical Journal|July 18, 2012
Underuse of statins in patients with atherosclerotic ischemic stroke in ChinaXi Li, Yan Gao, Jing Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney diseaseColin Baigent, Martin Landray, Craig Leaper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.
Chinese Medical Journal|December 21, 2012
Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patientsJing Li, Yi-ping Chen, Xi Li, et al.
JAMA Cardiology|December 16, 2016
Feasibility of Obtaining Measures of Lifestyle From a Smartphone App: The MyHeart Counts Cardiovascular Health StudyMichael V McConnell, Anna Shcherbina, Aleksandra Pavlovic, et al.
Pageof 5